Mirxes

About:

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Website: http://www.mirxes.com

Twitter/X: MiRXESInsights

Top Investors: The Agency for Science, Technology and Research, EDBI, Mitsui & Co, Rock Springs Capital, Charoen Pokphand Group

Description:

Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.

Total Funding Amount:

$218M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2014-01-01

Contact Email:

info(AT)mirxes.com

Hub Tags:

Emerging Unicorn

Founders:

Zhou Lihan, Zou Ruiyang

Number of Employees:

251-500

Last Funding Date:

2023-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai